Aaron Seth Rosenberg

Title(s)Assistant Professor, Hematology and Oncology
SchoolSchool of Medicine
AddressCancer Center
CA 95817
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. From mechanism to resistance - changes in the use of dexamethasone in the treatment of multiple myeloma. Leuk Lymphoma. 2023 02; 64(2):283-291. Rosenberg AS. PMID: 36308022.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center. Leuk Res. 2022 08; 119:106885. Othman T, Moskoff BN, Ho G, Tenold ME, Azenkot T, Krackeler ML, Fisch SC, Potter LA, Kaesberg PR, Welborn JL, Wun T, Esteghamat NS, Hoeg RT, Rosenberg AS, Abedi M, Tuscano JM, Jonas BA. PMID: 35738024.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    3. Allogeneic hematopoietic cell transplantation using non-myeloablative ATG/TLI conditioning for lymphomas. Leuk Lymphoma. 2022 01; 63(1):231-234. Othman T, Moskoff BN, Esteghamat N, Hoeg RT, Rosenberg AS, Jonas BA, Abedi M, Richman C, Tuscano JM. PMID: 34486920.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Outcomes of Adults With Relapsed/Refractory Acute Myeloid Leukemia Treated With Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer Center. Front Oncol. 2021; 11:649209. Tenold ME, Moskoff BN, Benjamin DJ, Hoeg RT, Rosenberg AS, Abedi M, Tuscano JM, Jonas BA. PMID: 33777810; PMCID: PMC7991747.
      View in: PubMed   Mentions: 20  
    5. Retrospective Analysis of Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia Treated with FLAG at a Comprehensive Cancer Center. Clin Lymphoma Myeloma Leuk. 2021 07; 21(7):e611-e618. Tenold ME, Moskoff BN, Krishnan R, Rosenberg AS, Hoeg RT, Abedi M, Tuscano JM, Jonas BA. PMID: 33811007.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Phase I study of escalating doses of carfilzomib with HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemia. Am J Hematol. 2021 04 01; 96(4):E114-E117. Jonas BA, Fisch SC, Rosenberg AS, Hoeg RT, Tuscano JM, Abedi M. PMID: 33476436.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    7. Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients. Blood Cancer J. 2021 01 07; 11(1):5. Rosenberg AS, Brunson A, Tuscano J, Jonas BA, Hoeg R, Wun T, Keegan THM. PMID: 33414400; PMCID: PMC7791054.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    8. Association of Morbid Progression With Overall Survival Among Patients With Multiple Myeloma: Validation of the Progression-free Survival Endpoint. Clin Lymphoma Myeloma Leuk. 2021 05; 21(5):345-354.e4. Rosenberg AS, Facon T, Parikh K, Chung W, Srinivasan S, Kotey S, Tuscano J. PMID: 33563582.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. Second primary malignancies in multiple myeloma: A review. Blood Rev. 2021 03; 46:100757. Poh C, Keegan T, Rosenberg AS. PMID: 32972803; PMCID: PMC8282231.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansPHPublic Health
    10. Association Between Autologous Stem Cell Transplant and Survival Among Californians With Multiple Myeloma. J Natl Cancer Inst. 2019 01 01; 111(1):78-85. Rosenberg AS, Brunson A, Jonas BA, Keegan THM, Wun T. PMID: 29897481; PMCID: PMC6335109.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    11. Platelet response to direct thrombin inhibitor or fondaparinux treatment in patients with suspected heparin-induced thrombocytopenia. J Thromb Thrombolysis. 2018 May; 45(4):536-542. Pon TK, Mahajan A, Rosenberg A, Amin A, Shah D, Jenkins I, Gupta V, Hofmann H, Bejjani A, White R. PMID: 29574610.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    12. Decreased early mortality associated with the treatment of acute myeloid leukemia at National Cancer Institute-designated cancer centers in California. Cancer. 2018 05 01; 124(9):1938-1945. Ho G, Wun T, Muffly L, Li Q, Brunson A, Rosenberg AS, Jonas BA, Keegan THM. PMID: 29451695; PMCID: PMC6911353.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    13. Assessing the Effect of Adherence on Patient-reported Outcomes and Out of Pocket Costs Among Patients With Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2018 03; 18(3):210-218. Gupta S, Abouzaid S, Liebert R, Parikh K, Ung B, Rosenberg AS. PMID: 29429817.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    14. Impact of latency time on survival for adolescents and young adults with a second primary malignancy. Cancer. 2018 03 15; 124(6):1260-1268. Goldfarb M, Rosenberg AS, Li Q, Keegan THM. PMID: 29205296.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    15. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors. JAMA Oncol. 2017 Nov 01; 3(11):1554-1557. Keegan THM, Bleyer A, Rosenberg AS, Li Q, Goldfarb M. PMID: 28426850; PMCID: PMC5824209.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    16. Secondary acute lymphoblastic leukemia is a distinct clinical entity with prognostic significance. Blood Cancer J. 2017 09 08; 7(9):e605. Rosenberg AS, Brunson A, Paulus JK, Tuscano J, Wun T, Keegan THM, Jonas BA. PMID: 28885611; PMCID: PMC5709750.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    17. Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era. Br J Haematol. 2017 07; 178(1):72-80. Tao L, Clarke CA, Rosenberg AS, Advani RH, Jonas BA, Flowers CR, Keegan THM. PMID: 28542862; PMCID: PMC5487277.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    18. Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality. Br J Haematol. 2017 07; 178(2):319-326. Brunson A, Lei A, Rosenberg AS, White RH, Keegan T, Wun T. PMID: 28369826.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    19. Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders. Clin Lymphoma Myeloma Leuk. 2016 12; 16(12):684-692.e3. Rosenberg AS, Ruthazer R, Paulus JK, Kent DM, Evens AM, Klein AK. PMID: 27771291; PMCID: PMC5402751.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    20. Investigation into the interference of the monoclonal antibody daratumumab on the free light chain assay. Clin Biochem. 2016 Oct; 49(15):1202-1204. Rosenberg AS, Bainbridge S, Pahwa R, Jialal I. PMID: 27475249.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    21. Hodgkin lymphoma post-transplant lymphoproliferative disorder: A comparative analysis of clinical characteristics, prognosis, and survival. Am J Hematol. 2016 06; 91(6):560-5. Rosenberg AS, Klein AK, Ruthazer R, Evens AM. PMID: 26928381; PMCID: PMC6586231.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    22. Breast cancer and thrombosis: timing matters. Blood. 2016 Feb 18; 127(7):793-4. Paulus JK, Rosenberg AS. PMID: 26893393.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    23. Incidence and evaluation of incidental abnormal bone marrow signal on magnetic resonance imaging. ScientificWorldJournal. 2014; 2014:380814. Shah GL, Rosenberg AS, Jarboe J, Klein A, Cossor F. PMID: 25374938; PMCID: PMC4211153.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    24. Imatinib and prostate cancer: lessons learned from targeting the platelet-derived growth factor receptor. Expert Opin Investig Drugs. 2013 Jun; 22(6):787-94. Rosenberg A, Mathew P. PMID: 23540855.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    With one click, see people who:

    Mentor Faculty

    Offer Student Projects

    Run Clinical Trials

    See more options in the Advanced Search tab

    Aaron's Networks
    Concepts (131)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (16)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UC Davis Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-1-g3264e86e on PROFILES-PWEB03. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California